Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

Driven by rising rates of high blood pressure, obesity, and other key risk factors, heart disease remains the leading cause ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

If you’re looking to embrace a healthier lifestyle this year, you can become more vigilant by reducing your intake ...

A study from King's College London says that researchers have found a novel link between lipids and disorders affecting ...

Li, Y. and Zhou, B. (2025) Research Progress on the Relationship between Dynapenic Obesity and Type 2 Diabetes. Journal of Biosciences and Medicines, 13, 256-267. doi: 10.4236/jbm.2025.132020 .

Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...